REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27/07/2026
Voltar para busca
Dado oficial do USPTO
VANTAI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
27/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
14/01/2020
Data de registro
27/07/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/07/2021
Última transação
27/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
2019-08-00
Primeiro uso no comércio
2019-08-00
Código do desenho
4
Tipo de titular
03
Localização do titular
New York, NY, US
Examinador
LE, MARGARET
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
VantAI, Inc.
Vant AI, Inc.
Representantes
Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and advisory services in the field of healthcarepharmaceuticals and biomedicine; business analysis and statistical analysis of healthcare datapharmaceuticalsbiomedical researchfor clinical trial and post-market data; systematization and compilation of data in computer databasesin particular compilation of information into computer databases for research and analysis purposes in the field of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical trials and post-market data; business services provided to the healthcare industrythe collectionreportingprofessional business analysis of healthcare data for drug research and development; none of the foregoing services include the provision and maintenance of software for use in computer and IT systems management and analyticsIT asset management and analyticssecurity management and analyticsmobility management and analyticsservice management and analyticsuser workspace and desktop system managementcustomer relationship managementuser permission and authorization management and supply chain management
Classe 42
Computer analysis of technical research data in the field of healthcarepharmaceuticals and biomedicine; pharmaceutical and biomedical research services; scientific research in the field of pharmaceutical and biologic therapeutic preparations; providing scientific research information in the field of pharmaceuticals and biomedicine; providing temporary use of online non-downloadable computer software allowing to connect to databases containing pharmaceutical and medical information related to drug research and development; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientificmedical and clinical information; providing temporary use of online non-downloadable computer software for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical drug research and developmentclinical and post-market trials for drug research and development; statistical analysis and reporting for pharmaceutical and biomedical research enabled by artificial intelligence and machine learning for the purpose of drug research and development; none of the foregoing services include the provision and maintenance of software for use in computer and IT systems management and analyticsIT asset management and analyticssecurity management and analyticsmobility management and analyticsservice management and analyticsuser workspace and desktop system managementcustomer relationship managementuser permission and authorization management and supply chain management
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
27/07/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
17/06/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
09/06/2021
APET
ASSIGNED TO PETITION STAFF
08/06/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
07/06/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
26/05/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
15/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/12/2020
PUBO
PUBLISHED FOR OPPOSITION
08/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/10/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/04/2020
GNRT
NON-FINAL ACTION E-MAILED
30/04/2020
CNRT
NON-FINAL ACTION WRITTEN
30/04/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
29/04/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
28/04/2020
ALIE
ASSIGNED TO LIE
13/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
06/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
06/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/04/2020
DOCK
ASSIGNED TO EXAMINER
01/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/01/2020
NWAP
NEW APPLICATION ENTERED
17/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VANTAI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.